What Happens After Stopping GLP-1 Medications? Real-World Study Shows Modest Weight Regain

Johnson & Johnson Expands U.S. Availability Of Intraocular Lens

Johnson & Johnson’s new FDA-approved EDOF intraocular lens expands cataract surgery options by improving vision across distances, reducing reading-glass dependence, and minimizing common visual disturbances.

Redefining the Adjuvant Landscape and Radiation Sequencing in Merkel Cell Carcinoma

New evidence supports sequential pembrolizumab after radiotherapy for high-risk Merkel cell carcinoma, reducing disease recurrence, preventing distant metastases, and reshaping multidisciplinary postoperative treatment strategies.

Preventing Recurrent Ischemic Stroke With Heart-Brain Clinic

Heart–brain clinics unite neurologists and cardiologists to identify stroke causes faster, personalize prevention strategies, reduce recurrent strokes, streamline testing, and improve long-term patient outcomes.

Tricuspid Regurgitation: Simple Clinical Risk Score For Mortality

A practical tricuspid regurgitation risk score combines symptoms, imaging, labs, and comorbidities to predict prognosis, guide timely referrals, personalize treatment, and improve patient outcomes.

Arizona’s First Heart Transplant Using ‘Heart In A Box’ Perfusion

Arizona’s first heart-in-a-box transplant showcases warm perfusion technology, extending donor heart preservation, expanding transplant opportunities, improving organ assessment, and offering hope for patients nationwide awaiting.